Suppr超能文献

新型见解:高迁移率族蛋白 B1 介导的脓毒症细胞免疫反应:系统综述。

Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.

机构信息

Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese People's Liberation Army General Hospital, Beijing 100048, China.

出版信息

World J Emerg Med. 2012;3(3):165-71. doi: 10.5847/wjem.j.issn.1920-8642.2012.03.001.

Abstract

BACKGROUND

High mobility group box 1 protein (HMGB1) is a highly conserved, ubiquitous protein in the nuclei and cytoplasm of nearly all cell types. HMGB1 is secreted into the extracellular milieu and acts as a proinfl ammatory cytokine. In this article we reviewed briefl y the cellular immune response mediated by HMGB1 in infl ammation and sepsis.

METHODS

This systemic review is mainly based on our own work and other related reports.

RESULTS

HMGB1 can actively affect the immune functions of many types of cells including T lymphocytes, regulatory T cells (Tregs), dendritic cells (DCs), macrophages, and natural killer cells (NK cells). Various cellular responses can be mediated by HMGB1 which binds to cell-surface receptors [e.g., the receptor for advanced glycation end products (RAGE), Toll-like receptor (TLR)2, and TLR4]. Anti-HMGB1 treatment, such as anti-HMGB1 polyclonal or monoclonal antibodies, inhibitors (e.g., ethyl pyruvate) and antagonists (e.g., A box), can protect against sepsis lethality and give a wider window for the treatment opportunity.

CONCLUSION

HMGB1 is an attractive target for the development of new therapeutic strategies in the treatment of patients with septic complications.

摘要

背景

高迁移率族蛋白 B1(HMGB1)是一种高度保守、普遍存在于几乎所有细胞类型的核和细胞质中的蛋白质。HMGB1 被分泌到细胞外环境中,并作为一种促炎细胞因子发挥作用。本文简要综述了 HMGB1 在炎症和脓毒症中介导的细胞免疫反应。

方法

本综述主要基于我们自己的工作和其他相关报道。

结果

HMGB1 可以主动影响包括 T 淋巴细胞、调节性 T 细胞(Tregs)、树突状细胞(DCs)、巨噬细胞和自然杀伤细胞(NK 细胞)在内的多种类型细胞的免疫功能。HMGB1 可以通过与细胞表面受体(如晚期糖基化终产物受体(RAGE)、Toll 样受体(TLR)2 和 TLR4)结合来介导各种细胞反应。抗-HMGB1 治疗,如抗-HMGB1 多克隆或单克隆抗体、抑制剂(如丙酮酸乙酯)和拮抗剂(如 A 盒),可以防止脓毒症的致死性,并为治疗提供更宽的窗口。

结论

HMGB1 是开发治疗脓毒症并发症患者的新治疗策略的有吸引力的靶点。

相似文献

1
Novel insights for high mobility group box 1 protein-mediated cellular immune response in sepsis: A systemic review.
World J Emerg Med. 2012;3(3):165-71. doi: 10.5847/wjem.j.issn.1920-8642.2012.03.001.
2
Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Arch Pharm Res. 2012 Sep;35(9):1511-23. doi: 10.1007/s12272-012-0901-5. Epub 2012 Oct 9.
3
Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Hum Reprod. 2015 Feb;30(2):417-31. doi: 10.1093/humrep/deu320. Epub 2014 Dec 1.
4
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.
Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9.
7
The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats.
J Interferon Cytokine Res. 2009 Oct;29(10):677-86. doi: 10.1089/jir.2008.0104.
8
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.
Eur J Pharmacol. 2019 Sep 5;858:172487. doi: 10.1016/j.ejphar.2019.172487. Epub 2019 Jun 20.
9
HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Shock. 2006 Aug;26(2):174-9. doi: 10.1097/01.shk.0000225404.51320.82.

引用本文的文献

1
HMGB1/RAGE Signaling Regulates Th17/IL-17 and Its Role in Bronchial Epithelial-Mesenchymal Transformation.
Curr Mol Med. 2024;24(11):1401-1412. doi: 10.2174/0115665240249953231024060610.
5
High Mobility Group Proteins in Sepsis.
Front Immunol. 2022 Jun 2;13:911152. doi: 10.3389/fimmu.2022.911152. eCollection 2022.
6
Molecular mechanisms of lidocaine.
Ann Med Surg (Lond). 2021 Aug 17;69:102733. doi: 10.1016/j.amsu.2021.102733. eCollection 2021 Sep.
7
High-mobility group box1 as an amplifier of immune response and target for treatment in keratitis.
Int J Ophthalmol. 2020 May 18;13(5):708-717. doi: 10.18240/ijo.2020.05.03. eCollection 2020.
8
Association between HMGB1 and asthma: a literature review.
Clin Mol Allergy. 2017 Jun 14;15:12. doi: 10.1186/s12948-017-0068-1. eCollection 2017.
9
The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats.
J Korean Med Sci. 2017 Mar;32(3):542-551. doi: 10.3346/jkms.2017.32.3.542.
10
Innate immunity gene expression changes in critically ill patients with sepsis and disease-related malnutrition.
Cent Eur J Immunol. 2015;40(3):311-24. doi: 10.5114/ceji.2015.54593. Epub 2015 Oct 15.

本文引用的文献

2
TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A).
Cytokine. 2012 Feb;57(2):210-20. doi: 10.1016/j.cyto.2011.11.011. Epub 2011 Dec 6.
4
Sepsis leads to a reduced antigen-specific primary antibody response.
Eur J Immunol. 2012 Feb;42(2):341-52. doi: 10.1002/eji.201141692. Epub 2011 Dec 20.
7
Surviving sepsis: going beyond the guidelines.
Ann Intensive Care. 2011 Jun 7;1(1):17. doi: 10.1186/2110-5820-1-17.
10
Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models.
Mol Med. 2011 Sep-Oct;17(9-10):1039-44. doi: 10.2119/molmed.2010.00264. Epub 2011 Jun 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验